ArticleOncoimmunology

Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer.

Saul J Priceman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.